Vitamin D and rosuvastatin obliterate peripheral neuropathy in a type-2 diabetes model through modulating Notch1, Wnt-10α, TGF-β and NRF-1 crosstalk
Publication date: 15 August 2021Source: Life Sciences, Volume 279Author(s): Engie S. El-Sawaf, Samira Saleh, Dalaal M. Abdallah, Kawkab A. Ahmed, Hanan S. El-Abhar
Source: Life Sciences - Category: Biology Source Type: research
More News: Biology | Brain | Crestor | Diabetes | Diabetes Type 2 | Endocrinology | Neurology | Peripheral Neuropathy | Rosuvastatin | Vitamin D | Vitamins